Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-455,701
Closed -$2.03M 424
2025
Q2
$2.03M Sell
455,701
-47,207
-9% -$175K 0.06% 157
2025
Q1
$1.46M Sell
502,908
-23,315
-4% -$102K 0.03% 149
2024
Q4
$2.58M Buy
526,223
+86,990
+20% +$438K 0.06% 132
2024
Q3
$2.13M Sell
439,233
-18,504
-4% -$85K 0.05% 161
2024
Q2
$1.97M Sell
457,737
-168,522
-27% -$579K 0.06% 196
2024
Q1
$1.6M Buy
626,259
+25,000
+4% +$35.6K 0.05% 221
2023
Q4
$597K Buy
601,259
+43,952
+8% +$40.3K 0.02% 331
2023
Q3
$736K Buy
557,307
+85,000
+18% +$139K 0.01% 361
2023
Q2
$935K Buy
472,307
+41,832
+10% +$86.2K 0.02% 389
2023
Q1
$827K Buy
+430,475
New +$969K 0.02% 430

Other funds holding RZLT

UBS O'Connor's RZLT Position: Q3 2025 in Review

UBS O'Connor sold out of Rezolute (RZLT) in Q3 2025, closing a stake of 455,701 shares — an estimated $2.03M sold.

UBS O'Connor first reported a position in RZLT in Q1 2023 and held it in 10 quarters. The position peaked at $2.58M in Q4 2024. 116 funds tracked by Wall St. Rank hold RZLT as of Q3 2025.

  • UBS O'Connor reported no remaining Rezolute position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 455,701 Rezolute shares in Q3 2025, an estimated $2.03M.
  • UBS O'Connor first reported a position in Rezolute in Q1 2023 and held it in 10 quarters.
  • UBS O'Connor's Rezolute position peaked at $2.58M in Q4 2024.
  • 116 funds tracked by Wall St. Rank held Rezolute as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.